Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip

Orthopedic Disorder Clinical Trial

Official title:

The Role of Ligamentum Teres Tenodesis in the Management of Developmental Dysplasia of the Hip

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05432505
• Other study ID #: LTT
• Status: Not yet recruiting
• Start date: July 21, 2022
• Est. completion date: February 2023

Study information

• Verified date: June 2022
• Source: Al-Azhar University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize complications during early treatment, and refine the selection of patients who can best benefit from hip preservation surgery. The ideal continued target would be to prevent missed hip dislocations or dysplasia during the infant period, prevent avascular necrosis (AVN) during early treatment, and decrease the incidence of total hip arthroplasty in adulthood related to undertreated DDH, The goal of the treatment is to achieve a concentric reduction of the femoral head into the acetabulum.

Description:

it is an operative technique to secure the femoral head after reduction in cases of developmental dysplasia of the hip Operative technique: The surgery will be accomplished under a general anesthesia. An addition to the steps of the open reduction, the following were done: 1. Identification of ligamentum teres 2. ligamentum teres tenodesis

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: February 2023
• Est. primary completion date: January 2023
• Gender: All
• Age group: 9 Months to 60 Months

Eligibility

Inclusion Criteria:

• Patient with Developmental dysplasia of the hip (DDH) with :
• Age: from 9 months -5 years old.
• Virgin DDH.
• Failed closed reduction in the management of DDH.
• Failed open reduction through medial approach in the management of DDH

Exclusion Criteria:

• • Paralytic hip dislocation .
• Post septic hip dislocation.
• Traumatic hip dislocation .
• Age : below 9 months or above 5 years.
• Refusal to participate in this study.

Related Conditions & MeSH terms

• Developmental Dysplasia of the Hip
• Hip Dislocation, Congenital
• Musculoskeletal Diseases
• Orthopedic Disorder

Intervention

Other:
• ligamentum teres tenodesis
Identification of ligamentum teres ligamentum teres tenodesis

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

References & Publications (2)

Schaeffer EK, Study Group I, Mulpuri K. Developmental dysplasia of the hip: addressing evidence gaps with a multicentre prospective international study. Med J Aust. 2018 May 7;208(8):359-364. Review. — View Citation

Zhang S, Doudoulakis KJ, Khurwal A, Sarraf KM. Developmental dysplasia of the hip. Br J Hosp Med (Lond). 2020 Jul 2;81(7):1-8. doi: 10.12968/hmed.2020.0223. Epub 2020 Jul 6. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	modified HHS	score for function of the hip	6 months